Literature DB >> 18175282

Detection and measurement of microparticles: an evolving research tool for vascular biology.

Anoop K Enjeti1, Lisa F Lincz, Michael Seldon.   

Abstract

Microparticles are small, membrane-bound vesicles that are generated from cells of different origin. It now appears that all circulating blood cells as well as endothelial cells release membranous fragments ~1 mum in size or smaller bearing at least some characteristics of the parent cell. Elevated levels of microparticles have been described in cardiovascular states, thrombotic conditions, and cancer. Various methods of detection for microparticles include flow cytometry, enzyme-linked immunoassays, and functional assays. Flow cytometry has several advantages including its ability to quantitate and identify microparticles of different cellular origin. However, the standardization of preanalytical and analytical variables for enumeration of microparticles remains a significant challenge. Newer approaches are being investigated, and an international collaboration is working on standardization of detection as well as quantitation of microparticles by flow cytometry. Although it has evolved as an important vascular biology research tool, microparticle detection needs further evaluation and refinement before it becomes truly useful as a clinical tool.

Entities:  

Mesh:

Year:  2007        PMID: 18175282     DOI: 10.1055/s-2007-1000369

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  23 in total

1.  Methodology for isolation, identification and characterization of microvesicles in peripheral blood.

Authors:  Muthuvel Jayachandran; Virginia M Miller; John A Heit; Whyte G Owen
Journal:  J Immunol Methods       Date:  2011-10-29       Impact factor: 2.303

Review 2.  The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases.

Authors:  Paolo Puddu; Giovanni M Puddu; Eleonora Cravero; Silvia Muscari; Antonio Muscari
Journal:  Can J Cardiol       Date:  2010-04       Impact factor: 5.223

3.  Isolation and phenotypic characteristics of microparticles in acute respiratory distress syndrome.

Authors:  Hongxia Li; Xiangyu Meng; Yue Gao; Shaohua Cai
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 4.  Microparticle analysis in disorders of hemostasis and thrombosis.

Authors:  Micah J Mooberry; Nigel S Key
Journal:  Cytometry A       Date:  2015-02-20       Impact factor: 4.355

Review 5.  Circulating membrane-derived microvesicles in redox biology.

Authors:  Michael Craig Larson; Cheryl A Hillery; Neil Hogg
Journal:  Free Radic Biol Med       Date:  2014-04-18       Impact factor: 7.376

6.  Microparticle enlargement and altered surface proteins after air decompression are associated with inflammatory vascular injuries.

Authors:  Ming Yang; Tatyana N Milovanova; Marina Bogush; Günalp Uzun; Veena M Bhopale; Stephen R Thom
Journal:  J Appl Physiol (1985)       Date:  2011-09-29

7.  Carbon monoxide inhalation increases microparticles causing vascular and CNS dysfunction.

Authors:  Jiajun Xu; Ming Yang; Paul Kosterin; Brian M Salzberg; Tatyana N Milovanova; Veena M Bhopale; Stephen R Thom
Journal:  Toxicol Appl Pharmacol       Date:  2013-09-30       Impact factor: 4.219

8.  Phosphatidylethanolamine is externalized at the surface of microparticles.

Authors:  Michael C Larson; Jeffrey E Woodliff; Cheryl A Hillery; Tyce J Kearl; Ming Zhao
Journal:  Biochim Biophys Acta       Date:  2012-08-30

9.  Proteomic characteristics of circulating microparticles in patients with newly-diagnosed type 2 diabetes.

Authors:  Min-Dan Xu; Xian-Zheng Wu; Yun Zhou; Ying Xue; Ke-Qin Zhang
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

10.  Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop.

Authors:  R Lacroix; C Judicone; M Mooberry; M Boucekine; N S Key; F Dignat-George
Journal:  J Thromb Haemost       Date:  2013-04-02       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.